![](/img/cover-not-exists.png)
287. Production of KTE-C19 (Anti-CD19 CAR T Cells) for ZUMA-1: A Phase 1/2 Multi-Center Study Evaluating Safety and Efficacy in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)
Better, Marc, Chiruvolu, Vijay, Oliver, James, Lowe, Emily, Rossi, John M., Perez, Arianne, Navale, Lynn, Bot, AdrianVolume:
24
Language:
english
Journal:
Molecular Therapy
DOI:
10.1016/s1525-0016(16)33096-9
Date:
May, 2016
File:
PDF, 337 KB
english, 2016